OR WAIT 15 SECS
September 17, 2015.
An analysis of 10.2 million adverse report records filed with the FDA along with survey of 123 health professionals by Tufts CSDD, found voluntary adverse drug event (ADE) reporting in the United States is incomplete, inaccurate, and inefficient.
Key findings from the studies, reported in the September/October Tufts CSDD Impact Report, included the following:
Read the full release.